Journal Mobile Options
Table of Contents
Vol. 38, No. 3, 2011
Issue release date: June 2011
Section title: Original Article · Originalarbeit
Free Access
Transfus Med Hemother 2011;38:195–198
(DOI:10.1159/000328634)

Platelet Recruitment during Multiple Donor Platelet Apheresis Differs between Cell Separators

Fontana S. · Keller P. · Taleghani B.
a Blood Transfusion Service of the Swiss Red Cross, b Department of Hematology and Central Hematology Laboratory, Division of Transfusion Medicine, Inselspital, University Hospital, Bern, Switzerland

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Abstract

Background: Recruitment of platelets (PLT) during donor PLT apheresis may facilitate the harvest of multiple units within a single donation. Methods: We compared two PLT apheresis procedures (Amicus and Trima Accel) in a prospective, randomized, paired cross-over study in 60 donors. The 120 donations were compared for depletion of circulating PLT in the donors, PLT yields and PLT recruitment. A recruitment was defined as ratio of total PLT yield and donor PLT depletion > 1. Results: Despite comparable differences of pre- and post-apheresis PLT counts (87 × 109/l in Trima Accel vs. 92 × 109/l in Amicus, p = 0.383), PLT yields were higher with Trima Accel (7.48 × 1011 vs. 6.06 × 1011, p < 0.001), corresponding to a higher PLT recruitment (1.90 vs. 1.42, p < 0.001). We observed a different increase of WBC counts after aphereses, which was more pronounced with Trima Accel than with Amicus (1.30 × 109/l vs. 0.46 × 109/l, p < 0.001). Conclusion: Both procedures induced PLT recruitment. This was higher in Trima Accel, contributing to a higher yield in spite of a comparable depletion of circulating PLT in the donors. This recruitment facilitates the harvest of multiple units within a single donation and seems to be influenced by the procedure utilized. The different increases of circulating donor white blood cells after donation need further investigation.


  

Author Contacts

Dr. Stefano Fontana, Blood Transfusion Service of the Swiss Red Cross, Murtenstrasse 133, 3008 Bern, Switzerland, Tel. +41 31 384-23 23, Fax -23, stefano.fontana@bsd-be.ch

  

Article Information

Received: November 11, 2010
Accepted: February 22, 2011
Published online: May 11, 2011
Number of Print Pages : 4

  

Publication Details

Transfusion Medicine and Hemotherapy

Vol. 38, No. 3, Year 2011 (Cover Date: June 2011)

Journal Editor: Sibrowski W. (Münster)
ISSN: 1660-3796 (Print), eISSN: 1660-3818 (Online)

For additional information: http://www.karger.com/TMH


Article / Publication Details

First-Page Preview
Abstract of Original Article &#x00B7; Originalarbeit

Received: 11/11/2010
Accepted: 2/22/2011
Published online: 5/11/2011

Number of Print Pages: 0
Number of Figures: 0
Number of Tables: 0

ISSN: 1660-3796 (Print)
eISSN: 1660-3818 (Online)

For additional information: http://www.karger.com/TMH


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.